HuGE Literature Finder
Records 1-6
Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.
Cancer chemotherapy and pharmacology 2015 Oct . Deenen Maarten J, Meulendijks Didier, Boot Henk, Legdeur Marie-Cecile J C, Beijnen Jos H, Schellens Jan H M, Cats Annemie |
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer.
BMC pharmacology & toxicology 2015 16 2. Lambrechts Sandrina, Lambrechts Diether, Despierre Evelyn, Van Nieuwenhuysen Els, Smeets Dominiek, Debruyne Philip R, Renard Vincent, Vroman Philippe, Luyten Daisy, Neven Patrick, Amant Frédéric, Leunen Karin, Vergote Ignace, |
Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer.
Cancer chemotherapy and pharmacology 2013 Jun 71 (6): 1463-72. Cortejoso Lucía, García María I, García-Alfonso Pilar, González-Haba Eva, Escolar Fernando, Sanjurjo María, López-Fernández Luis |
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.
Investigational new drugs 2012 Jun 30 (3): 1164-74. Oh Do-Youn, Lee Keun Wook, Lee Kyung-Hee, Sohn Chang-Hak, Park Young Suk, Zang Dae Young, Ryoo Hun-Mo, Song Hong-Suk, Kim Jin-Soo, Kang Hye-Jin, Kim Bong-Seog, Bang Yung-J |
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Jul 27 (21): 3540-6. Gandara David R, Kawaguchi Tomoya, Crowley John, Moon James, Furuse Kiyoyuki, Kawahara Masaaki, Teramukai Satoshi, Ohe Yuichiro, Kubota Kaoru, Williamson Stephen K, Gautschi Oliver, Lenz Heinz Josef, McLeod Howard L, Lara Primo N, Coltman Charles Arthur, Fukuoka Masahiro, Saijo Nagahiro, Fukushima Masanori, Mack Philip |
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: Combined analysis with translational research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 May 27 (15_suppl): 4607. Oh D, Lee K, Lee K, Sohn C, Park Y, Zang D, Ryoo H, Bang |
A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006 Nov 1 (9): 972-8. Pillot Giancarlo A, Read William L, Hennenfent Kristin L, Marsh Sharon, Gao Feng, Viswanathan Avinash, Cummings Kristopher, McLeod Howard L, Govindan Ramaswa |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: